Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013455-30Phase 2Active
Phase 2, open-label, single-arm trial of bleomycin in keloid and Hypertrophic Scar (HS), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Change in lesion dimension. Started Oct 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013455-30.